Related references
Note: Only part of the references are listed.Advanced lipid peroxidation end products in oxidative damage to proteins. Potential role in diseases and therapeutic prospects for the inhibitors
A. Negre-Salvayre et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
DNA damage induces two distinct modes of cell death in ovarian carcinomas
H. Vakifahmetoglu et al.
CELL DEATH AND DIFFERENTIATION (2008)
Activation of the mitochondrial death pathway is commonly mediated by a preferential engagement of Bak
D. Neise et al.
ONCOGENE (2008)
Diagnosing and exploiting cancer's addiction to blocks in apoptosis
Anthony G. Letai
NATURE REVIEWS CANCER (2008)
Apoptosis by cisplatin requires p53 mediated p38α MAPK activation through ROS generation
Paloma Bragado et al.
APOPTOSIS (2007)
Bcl-2 is the target of a UV-inducible apoptosis switch and a node for UV signaling
Dejan Knezevic et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Evidence that p53-Mediated Cell-Cycle-Arrest Inhibits Chemotherapeutic Treatment of Ovarian Carcinomas
Carlos S. Moreno et al.
PLOS ONE (2007)
Acute apoptosis by cisplatin requires induction of reactive oxygen species but is not associated with damage to nuclear DNA
Maria Berndtsson et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Apoptotic signaling in methylglyoxal-treated human osteoblasts involves oxidative stress, c-jun N-terminal kinase, caspase-3, and p21-activated kinase 2
Wen-Hsiung Chan et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2007)
Hierarchical regulation of mitochondrion-dependent apoptosis by BCL-2 subfamilies
Hyungjin Kim et al.
NATURE CELL BIOLOGY (2006)
Application of lipid peroxidation and protein oxidation biomarkers for oxidative damage in mammalian cells. A comparison with two fluorescent probes
H. Orhan et al.
TOXICOLOGY IN VITRO (2006)
Bcl-2 is a key regulator for the retinoic acid-induced apoptotic cell death in neuroblastoma
H. Niizuma et al.
ONCOGENE (2006)
The BH3-only protein, PUMA, is involved in oxaliplatin-induced apoptosis in colon cancer cells
Xinyiny Wang et al.
BIOCHEMICAL PHARMACOLOGY (2006)
Two distinct steps of Bak regulation during apoptotic stress signaling: Different roles of MEKK1 and JNK1
Linda Strandberg Ihrlund et al.
EXPERIMENTAL CELL RESEARCH (2006)
The proteasome inhibitor bortezomib induces apoptosis in mantle-cell lymphoma through generation of ROS and Noxa activation independent of p53 status
P Perez-Galan et al.
BLOOD (2006)
Recent advances in targeting regulators of apoptosis in cancer cells for therapeutic gain
Kathryn Taylor et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2006)
Bcl-2 attenuates anticancer agents-induced apoptosis by sustained activation of Akt/protein kinase B in U937 cells
KJ Woo et al.
APOPTOSIS (2005)
Mitochondrially targeted p53 has tumor suppressor activities in vivo
F Talos et al.
CANCER RESEARCH (2005)
PUMA couples the nuclear and cytoplasmic proapoptotic function of p53
JE Chipuk et al.
SCIENCE (2005)
Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins
SN Willis et al.
GENES & DEVELOPMENT (2005)
Proapoptotic BAX and BAK control multiple initiator caspases
A Ruiz-Vela et al.
EMBO REPORTS (2005)
Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function
L Chen et al.
MOLECULAR CELL (2005)
Sensitization for anticancer drug-induced apoptosis by betulinic acid
S Fulda et al.
NEOPLASIA (2005)
Mitochondrial p53 activates Bak and causes disruption of a Bak-Mcl1 complex
JIJ Leu et al.
NATURE CELL BIOLOGY (2004)
Antiapoptotic BCL-2 is required for maintenance of a model leukemia
A Letai et al.
CANCER CELL (2004)
In vivo mitochondrial p53 transloclation triggers a rapid first wave of cell death in response to DNA damage that can precede p53 target gene activation
S Erster et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
p53- and drug-induced apoptotic responses mediated by BH3-only proteins Puma and Noxa
A Villunger et al.
SCIENCE (2003)
Differential roles of hydrogen peroxide and hydroxyl radical in cisplatin-induced cell death in renal proximal tubular epithelial cells
SM Baek et al.
JOURNAL OF LABORATORY AND CLINICAL MEDICINE (2003)
Cisplatin induces endoplasmic reticulum stress and nucleus-independent apoptotic signaling
A Mandic et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
p53 has a direct apoptogenic role at the mitochondria
M Mihara et al.
MOLECULAR CELL (2003)
Activation of Bak, Bax, and BH3-only proteins in the apoptotic response to doxorubicin
T Panaretakis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Cellular toxicity of hydrazine in primary rat hepatocytes
SM Hussain et al.
TOXICOLOGICAL SCIENCES (2002)
Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics
A Letai et al.
CANCER CELL (2002)
A novel high-through-put assay for screening of pro-apoptotic drugs
M Hägg et al.
INVESTIGATIONAL NEW DRUGS (2002)
Adenovirus-mediated overexpression of p14ARF induces p53 and Bax-independent apoptosis
PG Hemmati et al.
ONCOGENE (2002)
Bax and Bak independently promote cytochrome c release from mitochondria
K Degenhardt et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
A role for mitochondrial Bak in apoptotic response to anticancer drugs
GQ Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
BCL-2, BCL-XL sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis
EHYA Cheng et al.
MOLECULAR CELL (2001)
Cisplatin induces the proapoptotic conformation of Bak in a ΔMEKK1-dependent manner
A Mandic et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
PUMA, a novel proapoptotic gene, is induced by p53
K Nakano et al.
MOLECULAR CELL (2001)
BCL-2 is involved in preventing oxidant-induced cell death and in decreasing oxygen radical production
PA Amstad et al.
REDOX REPORT (2001)
Nora, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis
E Oda et al.
SCIENCE (2000)
Share Paper
